MedTrace Logo

Detecting Autologous Transfusion by Measuring Alterations in the Dynamics of Red Blood Cell Maturation and Recycling

NCT02684747 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-05-14

No results posted yet for this study

Summary

A total of 40 subjects will be recruited for participation in this study. 20 subjects (10 males and 10 females) will be randomized to the active group (those receiving re-infusion of autologous blood) and 20 subjects (10 males and 10 females) will be randomized to the placebo group (receiving NS infusion).

Conditions

  • Blood Transfusion, Autologous
  • Blood Doping

Interventions

OTHER

Autologous Transfusion

Participants will receive autologous transfusion on Day 21

OTHER

Control - Normal Saline (Placebo)

Participants will receive saline on Day 21

Sponsors & Collaborators

  • Sports Medicine Research and Testing Laboratory

    collaborator INDUSTRY

  • Partnership for Clean Competition

    collaborator OTHER

  • University of Utah

    lead OTHER

Principal Investigators

  • Daniel Cushman, M.D. · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-05-05
Completion
2018-05-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02684747 on ClinicalTrials.gov